• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人胰腺癌细胞系HPC-YP分泌的组织蛋白酶L样酶的特性分析

Characterization of a cathepsin L-like enzyme secreted from human pancreatic cancer cell line HPC-YP.

作者信息

Yamaguchi N, Chung S M, Shiroeda O, Koyama K, Imanishi J

机构信息

Department of Microbiology, Kyoto Prefectural University of Medicine, Japan.

出版信息

Cancer Res. 1990 Feb 1;50(3):658-63.

PMID:2297706
Abstract

Spent culture medium from the human pancreatic carcinoma cell line HPC-YP, which can propagate in a protein-free, chemically defined medium without any other supplements, was analyzed for the presence of the cysteine protease, cathepsin L. The secreted form of cathepsin L was distinguished from the lysosomal form by its increased stability at alkaline pH, by its strong thermostability, and by its larger molecular size. HPC-YP cathepsin L was still stable at pH 7.4 and at 56 degrees C after 60-min preincubation. The molecular weight of this enzyme was estimated to be 68,000, compared with a molecular weight of 29,000 for normal liver cathepsin L. By Western blot analysis, HPC-YP enzyme was found to be composed of two components, one with a molecular weight of 37,000 and the other of 31,000. This result suggests that HPC-YP enzyme in the spent medium may be a complex of the proenzyme (in the case of liver proenzyme; Mr 39,000) and the mature enzyme (in the case of liver mature enzyme; Mr 29,000). Interestingly, an intrinsic inhibitor was also separated from the spent medium by gel filtration. The molecular weight of this inhibitor was estimated to be approximately 13,000. The cathepsin L of HPC-YP proved more resistant toward leupeptin than did liver cathepsin L. On the other hand, the former was more sensitive than the latter toward the diazomethane inhibitors, Z-Phe-Phe-CHN2 and Z-Phe-Ala-CHN2. These results indicate that cathepsin L secreted from cancer cell lines may play a role in the destruction of basal lamina, invasion of tissue, and formation of metastasis.

摘要

人胰腺癌细胞系HPC-YP的用过的培养基,该细胞系可在无蛋白、化学成分明确且无任何其他补充物的培养基中增殖,对其进行分析以检测半胱氨酸蛋白酶组织蛋白酶L的存在。组织蛋白酶L的分泌形式与溶酶体形式的区别在于,它在碱性pH下稳定性增强、具有很强的热稳定性且分子尺寸更大。HPC-YP组织蛋白酶L在60分钟预孵育后,在pH 7.4和56摄氏度时仍保持稳定。该酶的分子量估计为68,000,而正常肝脏组织蛋白酶L的分子量为29,000。通过蛋白质印迹分析发现,HPC-YP酶由两个组分组成,一个分子量为37,000,另一个为31,000。这一结果表明,用过的培养基中的HPC-YP酶可能是酶原(对于肝脏酶原;分子量39,000)和成熟酶(对于肝脏成熟酶;分子量29,000)的复合物。有趣的是,通过凝胶过滤还从用过的培养基中分离出了一种内源性抑制剂。该抑制剂的分子量估计约为13,000。HPC-YP的组织蛋白酶L比肝脏组织蛋白酶L对亮抑酶肽更具抗性。另一方面,前者比对重氮甲烷抑制剂Z-Phe-Phe-CHN2和Z-Phe-Ala-CHN2的敏感性比后者更高。这些结果表明,癌细胞系分泌的组织蛋白酶L可能在基底膜的破坏、组织侵袭和转移形成中起作用。

相似文献

1
Characterization of a cathepsin L-like enzyme secreted from human pancreatic cancer cell line HPC-YP.人胰腺癌细胞系HPC-YP分泌的组织蛋白酶L样酶的特性分析
Cancer Res. 1990 Feb 1;50(3):658-63.
2
Rat mammary gland in culture secretes a stable high molecular weight form of cathepsin L.培养中的大鼠乳腺分泌一种稳定的高分子量组织蛋白酶L。
Biochem Biophys Res Commun. 1985 Aug 30;131(1):402-7. doi: 10.1016/0006-291x(85)91816-9.
3
[Characterization of an analog enzyme to cathepsin L produced by tumor cells].[肿瘤细胞产生的组织蛋白酶L模拟酶的特性研究]
C R Seances Soc Biol Fil. 1989;183(1):79-84.
4
The purification and properties of cathepsin L from rabbit liver.兔肝组织中组织蛋白酶L的纯化及性质研究
Biochem J. 1984 Jan 1;217(1):209-17. doi: 10.1042/bj2170209.
5
Acid protease secreted from human pancreatic carcinoma cell line HPC-YT into serum-free, chemically defined medium.从人胰腺癌细胞系HPC-YT分泌到无血清化学限定培养基中的酸性蛋白酶。
Cancer Res. 1986 Oct;46(10):5353-9.
6
Collagenolytic cysteine proteinases of bone tissue. Cathepsin B, (pro)cathepsin L and a cathepsin L-like 70 kDa proteinase.骨组织的胶原olytic半胱氨酸蛋白酶。组织蛋白酶B、(前)组织蛋白酶L和一种70 kDa的组织蛋白酶L样蛋白酶。
Biochem J. 1991 Oct 1;279 ( Pt 1)(Pt 1):167-74. doi: 10.1042/bj2790167.
7
Variant cathepsin L activity from gastric cancer tissue.来自胃癌组织的组织蛋白酶L活性变体
Jpn J Cancer Res. 1990 Aug;81(8):813-9. doi: 10.1111/j.1349-7006.1990.tb02650.x.
8
Immunodetection of cathepsins B and L present in and secreted from human pre-malignant and malignant colorectal tumour cell lines.对人癌前和恶性结直肠肿瘤细胞系中存在及分泌的组织蛋白酶B和L进行免疫检测。
Int J Cancer. 1989 Mar 15;43(3):478-86. doi: 10.1002/ijc.2910430323.
9
Human kidney cathepsins B and L. Characterization and potential role in degradation of glomerular basement membrane.人肾组织中的组织蛋白酶B和L。特性及其在肾小球基底膜降解中的潜在作用。
Biochem J. 1988 May 15;252(1):301-4. doi: 10.1042/bj2520301.
10
Cathepsin S. The cysteine proteinase from bovine lymphoid tissue is distinct from cathepsin L (EC 3.4.22.15).组织蛋白酶S。来自牛淋巴组织的半胱氨酸蛋白酶与组织蛋白酶L(EC 3.4.22.15)不同。
Biochem J. 1986 Dec 1;240(2):455-9. doi: 10.1042/bj2400455.

引用本文的文献

1
The baculoviruses occlusion-derived virus: virion structure and function.杆状病毒包涵体衍生病毒:病毒粒子的结构与功能
Adv Virus Res. 2007;69:99-165. doi: 10.1016/S0065-3527(06)69003-9.
2
Cathepsins B, L and D in inflammatory bowel disease macrophages and potential therapeutic effects of cathepsin inhibition in vivo.炎症性肠病巨噬细胞中的组织蛋白酶B、L和D以及组织蛋白酶抑制在体内的潜在治疗作用。
Clin Exp Immunol. 2006 Oct;146(1):169-80. doi: 10.1111/j.1365-2249.2006.03188.x.
3
Angiogenesis and cathepsin expression are prognostic factors in pancreatic adenocarcinoma after curative resection.
血管生成和组织蛋白酶表达是根治性切除术后胰腺腺癌的预后因素。
Int J Pancreatol. 2000 Aug;28(1):31-9. doi: 10.1385/IJGC:28:1:31.
4
Structural requirements for cathepsin B and cathepsin H inhibition by kininogens.
J Protein Chem. 1996 Aug;15(6):519-25. doi: 10.1007/BF01908533.
5
Collagenolytic cysteine proteinases of bone tissue. Cathepsin B, (pro)cathepsin L and a cathepsin L-like 70 kDa proteinase.骨组织的胶原olytic半胱氨酸蛋白酶。组织蛋白酶B、(前)组织蛋白酶L和一种70 kDa的组织蛋白酶L样蛋白酶。
Biochem J. 1991 Oct 1;279 ( Pt 1)(Pt 1):167-74. doi: 10.1042/bj2790167.
6
Proteases and proteolysis in the lysosome.溶酶体中的蛋白酶与蛋白水解作用。
Experientia. 1992 Feb 15;48(2):151-7. doi: 10.1007/BF01923508.